Oragenics
OGEN
17 hedge funds and large institutions have $39.2K invested in Oragenics in 2026 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 5 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
2.87% less ownership
Funds ownership: 4.37% → 1.5% (-2.9%)
15% less funds holding
Funds holding: 20 → 17 (-3)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
63% less capital invested
Capital invested by funds: $106K → $39.2K (-$66.6K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
2L
25 LLC
St. Louis,
Missouri
|
+$14.1K |
| 2 |
Jane Street
New York
|
+$7.76K |
| 3 |
SJIM
St. Johns Investment Management
Jacksonville,
Florida
|
+$1.05K |
| 4 |
SS
SBI Securities
Tokyo,
Japan
|
+$7 |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Pathstone Holdings
Englewood,
New Jersey
|
-$30.8K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$25.1K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$11.4K |
| 4 |
HF
HRT Financial
New York
|
-$10K |
| 5 |
VF
Virtu Financial
New York
|
-$10K |
OGEN Hedge Fund Activity: Q2 2026 in Review
17 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q2 2026, worth a combined $39.2K — down 63% from $106K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of OGEN and 2 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 3 added.
The largest buyer was 25 LLC, opening a new position worth an estimated $14.1K. The largest seller was Pathstone Holdings, exiting entirely with an estimated $30.8K sold.
- 17 institutional investors held Oragenics (OGEN) as of Q2 2026, down from 20 in Q1 2026.
- Funds reported $39.2K of Oragenics stock for Q2 2026, down 63% quarter-over-quarter.
- 2 funds opened new Oragenics positions in Q2 2026 and 5 closed out, a net change of -3 holders.
- The largest Oragenics buyer in Q2 2026 was 25 LLC, an estimated $14.1K added.
- The largest Oragenics seller in Q2 2026 was Pathstone Holdings, an estimated $30.8K sold.
Based on aggregated 13F filings for Q2 2026.